Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Kleber Yotsumoto Fertrin & Fernando Ferreira Costa. (2010) Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Review of Hematology 3:4, pages 443-458.
Read now
Read now
Miguel R. Abboud & Khaled M. Musallam. (2009) Sickle Cell Disease at the Dawn of the Molecular Era. Hemoglobin 33:sup1, pages S93-S106.
Read now
Read now
SAMIR K. BALLAS & NARLA MOHANDAS. (2004) Sickle Red Cell Microrheology and Sickle Blood Rheology. Microcirculation 11:2, pages 209-225.
Read now
Read now
Abdullah Kutlar, Ferdane Kutlar, Ibrahim Turker & Canan Tural. (2001) THE METHYLENE TETRAHYDROFOLATE REDUCTASE (C677T) MUTATION AS A POTENTIAL RISK FACTOR FOR AVASCULAR NECROSIS IN SICKLE CELL DISEASE. Hemoglobin 25:2, pages 213-217.
Read now
Read now
Samir K. Ballas. (2001) Effect of α-Globin Genotype on the Pathophysiology of Sickle Cell Disease. Pediatric Pathology & Molecular Medicine 20:2, pages 107-121.
Read now
Read now
S. K. Ballas, R. N. Gay & F. F. Chehab. (1997) Is Hb A2 Elevated in Adults with Sickle-A-Thalassemi (βS/βS; -α/-α). Hemoglobin 21:5, pages 405-420.
Read now
Read now
Articles from other publishers (41)
Justin K. Kirkham, Jeremie H. Estepp, Mitch J. Weiss & Sara R. Rashkin. (2023) Genetic Variation and Sickle Cell Disease Severity. JAMA Network Open 6:10, pages e2337484.
Crossref
Crossref
David C. Rees, Valentine A.M. Brousse & John N. Brewin. (2022) Determinants of severity in sickle cell disease. Blood Reviews 56, pages 100983.
Crossref
Crossref
John N. Brewin, Amina Nardo‐Marino, Sara Stuart‐Smith, Sara El Hoss, Anke Hanneman, John Strouboulis, Stephan Menzel, John S. Gibson & David C. Rees. (2022)
The pleiotropic effects of α‐thalassemia on
HbSS
and
HbSC
sickle cell disease: Reduced erythrocyte cation co‐transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival
. American Journal of Hematology 97:10, pages 1275-1285.
Crossref
Crossref
Betânia Lucena Domingues Hatzlhofer, Diego Antonio Pereira-Martins, Igor de Farias Domingos, Gabriela da Silva Arcanjo, Isabel Weinhäuser, Diego Arruda Falcão, Isabela Cristina Cordeiro Farias, Jéssica Vitória Gadelha de Freitas Batista, Luana Priscilla Laranjeira Prado, Jéssica Maria Florencio Oliveira, Thais Helena Chaves Batista, Marcondes José de Vasconcelos Costa Sobreira, Rodrigo Marcionilo de Santana, Amanda Bezerra de Sá Araújo, Manuela Albuquerque de Melo, Bruna Vasconcelos de Ancântara, Juan Luiz Coelho-Silva, Ana Beatriz Lucas de Moura Rafael, Danízia Menezes de Lima Silva, Flávia Peixoto Albuquerque, Magnun Nueldo Nunes Santos, Ana Cláudia dos Anjos, Fernando Ferreira Costa, Aderson da Silva Araújo, Antonio Roberto Lucena-Araújo & Marcos André Cavalcanti Bezerra. (2021) Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort. Annals of Hematology 100:4, pages 921-931.
Crossref
Crossref
Samir K. Ballas & Deepika S. Darbari. (2020) Review/overview of pain in sickle cell disease. Complementary Therapies in Medicine 49, pages 102327.
Crossref
Crossref
Graham R. Serjeant & Elliott Vichinsky. (2018) Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors. Blood Cells, Molecules, and Diseases 70, pages 66-77.
Crossref
Crossref
Céline Renoux, Philippe Joly, Camille Faes, Pauline Mury, Buse Eglenen, Mine Turkay, Gokce Yavas, Ozlem Yalcin, Yves Bertrand, Nathalie Garnier, Daniela Cuzzubbo, Alexandra Gauthier, Marc Romana, Berenike Möckesch, Giovanna Cannas, Sophie Antoine-Jonville, Vincent Pialoux & Philippe Connes. (2018) Association between Oxidative Stress, Genetic Factors, and Clinical Severity in Children with Sickle Cell Anemia. The Journal of Pediatrics 195, pages 228-235.
Crossref
Crossref
Alicia K. Chang, Carly C. Ginter Summarell, Parendi T. Birdie & Vivien A. Sheehan. (2018) Genetic modifiers of severity in sickle cell disease. Clinical Hemorheology and Microcirculation 68:2-3, pages 147-164.
Crossref
Crossref
Samir K. Ballas. (2018) Sickle cell disease: Classification of clinical complications and approaches to preventive and therapeutic management. Clinical Hemorheology and Microcirculation 68:2-3, pages 105-128.
Crossref
Crossref
Tite Minga Mikobi, Prosper Tshilobo Lukusa, Michel Ntetani Aloni, Aimé Lumaka, Pierre Zalagile Akilimali, Koenraad Devriendt, Gert Matthijs, Jean-Marie Mbuyi Muamba & Valerie Race. (2018)
Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α
3.7
triplication in congolese patients than in worldwide series
. Journal of Clinical Laboratory Analysis 32:1, pages e22186.
Crossref
Crossref
Nermi L. Parrow, Hongbin Tu, James Nichols, Pierre-Christian Violet, Corinne A. Pittman, Courtney Fitzhugh, Robert E. Fleming, Narla Mohandas, John F. Tisdale & Mark Levine. (2017) Measurements of red cell deformability and hydration reflect HbF and HbA 2 in blood from patients with sickle cell anemia. Blood Cells, Molecules, and Diseases 65, pages 41-50.
Crossref
Crossref
Lydia H. Pecker, Beverly A. Schaefer & Lori Luchtman-Jones. (2017) Knowledge insufficient: the management of haemoglobin SC disease. British Journal of Haematology 176:4, pages 515-526.
Crossref
Crossref
Joseph F. McLaughlin & Samir K. Ballas. (2016) High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program. Transfusion 56:5, pages 1014-1021.
Crossref
Crossref
Philippe Connes, Tamas Alexy, Jon Detterich, Marc Romana, Marie-Dominique Hardy-Dessources & Samir K. Ballas. (2016) The role of blood rheology in sickle cell disease. Blood Reviews 30:2, pages 111-118.
Crossref
Crossref
Samir K. Ballas. (2015) Pathophysiology and principles of management of the many faces of the acute vaso-occlusive crisis in patients with sickle cell disease. European Journal of Haematology 95:2, pages 113-123.
Crossref
Crossref
Perla Vicari, Samuel A. Adegoke, Diego Robles Mazzotti, Rodolfo Delfini Cançado, Maria Aparecida Eiko Nogutti & Maria Stella Figueiredo. (2015) Interleukin-1β and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia. Blood Cells, Molecules, and Diseases 54:3, pages 244-249.
Crossref
Crossref
Nathalie Lemonne, Yann Lamarre, Marc Romana, Martin Mukisi-Mukaza, Marie-Dominique Hardy-Dessources, Vanessa Tarer, Danielle Mougenel, Xavier Waltz, Benoît Tressières, Marie-Laure Lalanne-Mistrih, Maryse Etienne-Julan & Philippe Connes. (2013) Does increased red blood cell deformability raise the risk for osteonecrosis in sickle cell anemia?. Blood 121:15, pages 3054-3056.
Crossref
Crossref
Samir K. Ballas, Muge R. Kesen, Morton F. Goldberg, Gerard A. Lutty, Carlton Dampier, Ifeyinwa Osunkwo, Winfred C. Wang, Carolyn Hoppe, Ward Hagar, Deepika S. Darbari & Punam Malik. (2012) Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management. The Scientific World Journal 2012, pages 1-55.
Crossref
Crossref
Sanjay PandeySweta PandeyRahasya Mani MishraMonica SharmaRenu Saxena. (2011) Genotypic influence of α-deletions on the phenotype of Indian sickle cell anemia patients. The Korean Journal of Hematology 46:3, pages 192.
Crossref
Crossref
J.A. Olaniyi. (2008) Multiple Complications in a Sickle Cell Disease Patient: A Case Report. Clinical Medicine: Case Reports 1, pages CCRep.S812.
Crossref
Crossref
Gregory J. Kato, Mark T. Gladwin & Martin H. Steinberg. (2007) Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Reviews 21:1, pages 37-47.
Crossref
Crossref
G. MarulandaT. M. SeylerN. H. SheikhM. A. Mont. (2006) Percutaneous drilling for the treatment of secondary osteonecrosis of the knee. The Journal of Bone and Joint Surgery. British volume 88-B:6, pages 740-746.
Crossref
Crossref
Samir K. Ballas. (2005) Pain Management of Sickle Cell Disease. Hematology/Oncology Clinics of North America 19:5, pages 785-802.
Crossref
Crossref
Antonio Almeida & Irene Roberts. (2005) Bone involvement in sickle cell disease. British Journal of Haematology 129:4, pages 482-490.
Crossref
Crossref
M. H. Steinberg. (2005) Predicting clinical severity in sickle cell anaemia. British Journal of Haematology 129:4, pages 465-481.
Crossref
Crossref
Samir K. Ballas. (2002) Sickle Cell Anaemia. Drugs 62:8, pages 1143-1172.
Crossref
Crossref
A.D. Adekile, F. Kutlar, M.Z. Haider & A. Kutlar. (2001) Frequency of the 677 C→T mutation of the methylenetetrahydrofolate reductase gene among Kuwaiti sickle cell disease patients. American Journal of Hematology 66:4, pages 263-266.
Crossref
Crossref
D.J. Weatherall & J.B. Clegg. 2001. The Thalassaemia Syndromes. The Thalassaemia Syndromes
733
821
.
Samir K Ballas. (2000) Acute Chest Syndrome in Sickle Cell Anemia. Journal of Intensive Care Medicine 15:3, pages 123-125.
Crossref
Crossref
Samir K. Ballas. (2016) Acute Chest Syndrome in Sickle Cell Anemia. Journal of Intensive Care Medicine 15:3, pages 123-125.
Crossref
Crossref
M Mukisi-Mukaza, A Elbaz, Y Samuel-Leborgne, L Kélard, C Le Turdu-Chicot, E Christophe-Duchange & G Mérault. (2000) Prevalence, Clinical Features, and Risk Factors of Osteonecrosis of the Femoral Head Among Adults With Sickle Cell Disease. Orthopedics 23:4, pages 357-363.
Crossref
Crossref
Samir K. Ballas. (1998) 7 Sickle cell disease: clinical management. Baillière's Clinical Haematology 11:1, pages 185-214.
Crossref
Crossref
Jeanne A. Smith. (1996) BONE DISORDERS IN SICKLE CELL DISEASE. Hematology/Oncology Clinics of North America 10:6, pages 1345-1356.
Crossref
Crossref
Samir K. Ballas & Narla Mohandas. (1996) PATHOPHYSIOLOGY OF VASO-OCCLUSION. Hematology/Oncology Clinics of North America 10:6, pages 1221-1239.
Crossref
Crossref
M.S. Figueiredo, J. Kerbauy, M.S. Gonçalves, V.R. Arruda, S.T.O. Saad, M.F. Sonati, T. Stoming & F.F. Costa. (1996) Effect of α-thalassemia and β-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. American Journal of Hematology 53:2, pages 72-76.
Crossref
Crossref
Andrew Padmos, George Roberts, Sven Lindahl, Andreas Kulozik, Peter Thomas, Beryl Serjeant & Graham Serjeant. (1995) Avascular Necrosis of the Femoral Head in Saudi Arabians with Homozygous Sickle Cell Disease — Risk Factors. Annals of Saudi Medicine 15:1, pages 21-24.
Crossref
Crossref
Graham R. Serjeant. (1994) The Geography of Sickle Cell Disease: Opportunities for Understanding its Diversity. Annals of Saudi Medicine 14:3, pages 237-246.
Crossref
Crossref
Graham R. Serjeant. (1993) 4 The clinical features of sickle cell disease. Baillière's Clinical Haematology 6:1, pages 93-115.
Crossref
Crossref
Robert M. Steiner, Donald G. Mitchell, Vijay M. Rao & Mark E. Schweitzer. (1993) MAGNETIC RESONANCE IMAGING OF DIFFUSE BONE MARROW DISEASE. Radiologic Clinics of North America 31:2, pages 383-409.
Crossref
Crossref
Paul F. Milner, Alfred P. Kraus, Jeno I. Sebes, Lynn A. Sleeper, Kimberly A. Dukes, Stephen H. Embury, Rita Bellevue, Mabel Koshy, John W. Moohr & Jeanne Smith. (1991) Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral Head. New England Journal of Medicine 325:21, pages 1476-1481.
Crossref
Crossref
Martin H. Steinberg. (1991) The Interactions of α -Thalassemia with Hemoglobinopathies. Hematology/Oncology Clinics of North America 5:3, pages 453-473.
Crossref
Crossref